Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David B Price

Showing results (141-150 of 184) with videos related to

Pageof 19
Sort By:
Archivos De Bronconeumologia|July 26, 2020
Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International StudyMarc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Predictive value of control of COPD for risk of exacerbations: An international, prospective studyMarc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, et al.
Pragmatic and Observational Research|March 24, 2025
Real-World Biologic Use Patterns in Severe Asthma, 2015-2021: The CLEAR StudyTrung N Tran, Stephanie Chen, Benjamin Emmanuel, et al.
The European Respiratory Journal|July 22, 2017
Blood eosinophil count and exacerbation risk in patients with COPDMarjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, et al.
The Lancet. Respiratory Medicine|November 8, 2017
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trialDavid B Price, Roland Buhl, Adrian Chan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma OutcomesDavid B Price, Miguel Román-Rodríguez, R Brett McQueen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 25, 2017
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life StudiesSamatha Sonnappa, Brett McQueen, Dirkje S Postma, et al.
Allergy, Asthma & Immunology Research|January 20, 2017
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled CorticosteroidsDirkje S Postma, Richard Dekhuijzen, Thys van der Molen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 20, 2021
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD CareRachel Pullen, Marc Miravitlles, Anita Sharma, et al.
Journal of Asthma and Allergy|October 31, 2024
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma RegistryTham T Le, David B Price, Clement Erhard, et al.
Pageof 19

Showing results (141-150 of 184) with videos related to

Sort By:
Pageof 19
Archivos De Bronconeumologia|July 26, 2020
Changes in Control Status of COPD Over Time and Their Consequences: A Prospective International StudyMarc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, et al.
Respirology (Carlton, Vic.)|April 7, 2020
Predictive value of control of COPD for risk of exacerbations: An international, prospective studyMarc Miravitlles, Pawel Sliwinski, Chin Kook Rhee, et al.
Pragmatic and Observational Research|March 24, 2025
Real-World Biologic Use Patterns in Severe Asthma, 2015-2021: The CLEAR StudyTrung N Tran, Stephanie Chen, Benjamin Emmanuel, et al.
The European Respiratory Journal|July 22, 2017
Blood eosinophil count and exacerbation risk in patients with COPDMarjan Kerkhof, Samatha Sonnappa, Dirkje S Postma, et al.
The Lancet. Respiratory Medicine|November 8, 2017
Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trialDavid B Price, Roland Buhl, Adrian Chan, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 14, 2017
Inhaler Errors in the CRITIKAL Study: Type, Frequency, and Association with Asthma OutcomesDavid B Price, Miguel Román-Rodríguez, R Brett McQueen, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 25, 2017
Extrafine Versus Fine Inhaled Corticosteroids in Relation to Asthma Control: A Systematic Review and Meta-Analysis of Observational Real-Life StudiesSamatha Sonnappa, Brett McQueen, Dirkje S Postma, et al.
Allergy, Asthma & Immunology Research|January 20, 2017
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled CorticosteroidsDirkje S Postma, Richard Dekhuijzen, Thys van der Molen, et al.
International Journal of Chronic Obstructive Pulmonary Disease|August 20, 2021
CONQUEST Quality Standards: For the Collaboration on Quality Improvement Initiative for Achieving Excellence in Standards of COPD CareRachel Pullen, Marc Miravitlles, Anita Sharma, et al.
Journal of Asthma and Allergy|October 31, 2024
Disease Burden and Access to Biologic Therapy in Patients with Severe Asthma, 2017-2022: An Analysis of the International Severe Asthma RegistryTham T Le, David B Price, Clement Erhard, et al.
Pageof 19